Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 2017

View Archived Issues

FDA clears IND for phase II study of 177Lu-PSMA-617

Lupin identifies new PARP-1 inhibitors

Ono Pharmaceutical recaps milestones of third quarter of fiscal 2016

Clinical improvement in ADHD seen with fasoracetam in phase I trial, phase II/III study underway

AstraZeneca reviews milestones of fourth quarter 2016

Phase II trial results of RG-7667 for CMV infection prevention in kidney transplant recipients

HIF1-alpha identified as a target for relapsing triple-negative breast cancer

Longevity Biotech and UNMC awarded continuing grant for the development of LBT-3627

GW Pharmaceuticals reports topline results from phase II study of THC:CBD in glioblastoma

Nanjing Hairong, Nanjing Heron patent loxoprofen derivatives

FDA approves Parsabiv to treat secondary hyperparathyroidism in patients on hemodialysis

Amgen reflects on achievements of fourth quarter 2016

Sunshine Lake Pharma discloses 5-HT reuptake inhibitors/5-HT1A receptor agonists

Targeting zinc finger protein SNAI1 induces apoptosis in bladder cancer cells

Vyome Biosciences announces promising results for VB-1953

Marina Biotech signs licensing agreement for SMARTICLES platform

Flexion Therapeutics' Zilretta NDA accepted for review by FDA

FDA awards fast track designation to Angionetics' Generx

Investigator-sponsored phase I trial of Actinium Pharmaceuticals' Actimab-M begins

Buparlisib shows promise in patients with platinum-pretreated recurrent head and neck carcinoma

Acticor Biotech raises funds to advance lead candidate

GeNeuro, NINDS enter agreement regarding antibodies for ALS

Series B financing at Prexton Therapeutics to support phase II trials of foliglurax

Cancer Research Technology, Tusk Therapeutics and UCL collaborate on cancer immunotherapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...